← Back
$VRDN All transactions

Viridian Therapeutics, Inc.\DE

A

$ Value

$0

Shares

21,000

Price

$0

Filed

Jul 2

Insider

Name

CAIN CHRISTOPHER W.

Title

CIK

0001817733

Roles

Director

Transaction Details

Transaction Date

2025-07-01

Code

A

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

21,000

Footnotes

The option vests in full upon the earlier to occur of (i) July 1, 2026 or (ii) the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer. | Under the Reporting Person's arrangement with Fairmount Funds Management LLC (the "Adviser"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a "Fairmount Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.

Filing Info

Accession No.

0000950170-25-093118

Form Type

4

Issuer CIK

0001590750

CAIN CHRISTOPHER W.'s History

Date Ticker Type Value
2026-03-23 DMRA A $0
2025-07-01 VRDN A $0
2025-06-04 COGT A $0
2025-04-29 JBIO A $0

Other Insiders at VRDN (90d)

No other insider activity at this issuer in the last 90 days.